Related Experiment Videos
Spontaneous clostridial myonecrosis. A collective review and report of a case
Abstract:
A collected series from the English literature up to 1984 of spontaneous clostridial myonecrosis (SCM) is presented in order to reveal possible common denominators. SCM was associated with malignancy (colonic cancer and leukaemia), diabetes, and injections in descending order. C. perfringens was isolated in more than 70% of the cases followed by C. septicum in 27 and C. novyi in 7%. The pathogenesis is still speculative but is thought to be due to bacteraemia especially from the gastrointestinal tract, due to growth of dormant spores in tissue following antecedent trauma or as an infection descending along the ilio-psoas sheath from a gastrointestinal focus. The symptoms are pain in an oedematous, discoloured, crepitant area with haemorhagic bullae and often shock. The diagnosis is based on the clinical findings and Gram-positive rods in the exudate. Treatment instituted promptly constitutes of surgical debridement, antibiotics and hyperbaric oxygen. The prognosis of SCM is worse than for other cases of clostridial myonecrosis and survival was in this collected series only 19%.
Insights
Spontaneous clostridial myonecrosis (SCM) is linked to cancer, diabetes, and injections. Prompt treatment is crucial, but survival rates remain low at 19% for this serious infection.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Surgical Pathology
Background:
- Spontaneous clostridial myonecrosis (SCM) is a rare but severe condition.
- Understanding common denominators is essential for early diagnosis and improved outcomes.
Observation:
- A literature review up to 1984 identified malignancy (colonic cancer, leukemia), diabetes, and injections as key associations.
- Clostridium perfringens was the most common isolate (over 70%), followed by C. septicum (27%) and C. novyi (7%).
- Pathogenesis theories include bacteremia from the gastrointestinal tract or infection spread along fascial planes.
Findings:
- SCM presents with pain, edema, discoloration, crepitus, hemorrhagic bullae, and shock.
- Diagnosis relies on clinical presentation and identification of Gram-positive rods.
- Prompt treatment involves surgical debridement, antibiotics, and hyperbaric oxygen therapy.
Implications:
- SCM carries a poorer prognosis than other clostridial myonecroses, with a survival rate of only 19% in this series.
- Identifying risk factors like malignancy and diabetes can aid in clinical suspicion.
- Aggressive, multi-modal treatment is critical for managing this life-threatening infection.